GSK plc (GSK)
NYSE: GSK · Real-Time Price · USD
33.35
-0.65 (-1.91%)
Nov 15, 2024, 4:00 PM EST - Market closed
GSK Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for GSK stock have an average target of 45.5, with a low estimate of 44 and a high estimate of 47. The average target predicts an increase of 36.43% from the current stock price of 33.35.
Analyst Consensus: Hold
* Price targets were last updated on May 30, 2024.
Analyst Ratings
The average analyst rating for GSK stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 3 | 3 | 3 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Nov 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 31, 2024 |
| UBS | UBS | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jul 8, 2024 |
| Jefferies | Jefferies | Strong Buy Maintains $53 → $53 | Strong Buy | Maintains | $53 → $53 | +58.92% | Jul 2, 2024 |
| Goldman Sachs | Goldman Sachs | Hold Initiates $47 | Hold | Initiates | $47 | +40.93% | May 30, 2024 |
Financial Forecast
Revenue This Year
32.30B
from 30.33B
Increased by 6.50%
Revenue Next Year
33.77B
from 32.30B
Increased by 4.54%
EPS This Year
1.59
from 1.20
Increased by 32.36%
EPS Next Year
1.75
from 1.59
Increased by 10.29%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 34.0B | 36.7B | 40.1B | ||
| Avg | 32.3B | 33.8B | 35.8B | ||
| Low | 29.4B | 29.9B | 31.1B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.0% | 13.6% | 18.9% | ||
| Avg | 6.5% | 4.5% | 6.1% | ||
| Low | -3.2% | -7.4% | -8.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 1.72 | 1.94 | 2.26 | ||
| Avg | 1.59 | 1.75 | 1.95 | ||
| Low | 1.27 | 1.37 | 1.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 43.7% | 22.1% | 29.0% | ||
| Avg | 32.4% | 10.3% | 11.4% | ||
| Low | 6.3% | -13.6% | -11.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.